SecBot SecBot

CVM

CEL SCI CORP
NYSE· Biological Products, (No Diagnostic Substances)· Inc. CO· CIK 0000725363 Biotech & Drug Discovery
$1.59 −0.05 (−3.05%)
Oct 26 4:00 PM ET · prev $1.64
Market cap
$28.3M
Nano cap
Median target
$12.50
+686% · range $10.00–15.00
1 year
−82.4%
from $9.03 · Oct 27
30 days
−6.5%
from $1.70
52-week range
$0.9700–9.03
−82% from high · low Jun 25
Avg volume 20D
294.3K
Oct 1 spike 807.6K
Short interest
🔒 Subscribers only
Insider net
+$617.0K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read BEARISH 5 reports · latest
Balance 3 bearish · 1 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 3/5
Strongest BEARISH CEL-SCI Corporation completed a best-efforts offering of 2,500,000 shares at $1.00 per share for gross…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $617.0K at an average $1.23. No open-market sales. Price is 29% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 4 added (0 new), 1 trimmed or exited.

  • TrendRANGE

    7% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 1.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCDOUBLED572,460$595.4K
VANGUARD CAPITAL MANAGEMENT LLCDOUBLED543,079$564.8K
COMMONWEALTH EQUITY SERVICES, LLCDOUBLED51,434$53.5K
OSAIC HOLDINGS, INC.DOUBLED32,780$34.1K
UBS Group AGTRIM8,025$8.3K
RENAISSANCE TECHNOLOGIES LLCDOUBLED35,890$115.2K
US BANCORP \DE\ADD29,907$96.0K
UBS Group AGADD16,637$53.4K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jul 2023
12-month targets · 2 analysts

Price is below the lowest target. Median implies +686%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Jul 12, 2023EF Hutton
REITERATE
REITERATEBuy
Mar 9, 2023EF Hutton
REITERATE
REITERATEBuy
Dec 29, 2022EF Hutton
MAINTAIN
MAINTAINBuy
Apr 7, 2022EF Hutton
INITIATE
INITIATEBuy
Jan 13, 2020HC Wainwright & Co.
INITIATE
INITIATEBuy
Feb 20, 2013Taglich Brothers
INITIATE
INITIATESpeculative Buy

Insider ledger

Form 4
$617.0K
bought · 1 insider
$0
sold · 0 insiders
+28.8%
vs their $1.23 cost
DateInsiderTypeValue
Sep 30, 2026
KERSTEN GEERT R
Chief Executive Officer
AWARD$5.4K
Sep 30, 2026
PRICHEP PATRICIA B
Chief Financial Officer
AWARD$4.3K
Sep 30, 2026
TALOR EYAL
Chief Scientific Officer
AWARD$2.4K
Aug 25, 2026
KERSTEN GEERT R
Chief Executive Officer
BUY$138.0K
Aug 14, 2026
BAILLAVOINE BRUNO JEAN-MARIE
Director
AWARD$1.1K
Aug 14, 2026
Watson Robert Eugene
Director
AWARD$1.1K
Aug 14, 2026
TALOR EYAL
Chief Scientific Officer
AWARD$2.5K
Aug 14, 2026
CIPRIANO JOHN
Senior Vice President
AWARD$800.00

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY-$3.07-$3.07–-$3.07—$0.00
Next FY-$6.38-$6.38–-$6.38—$6.0M
Reddit
Recent posts
r/pennystocks Neutral 26d ago
CVM ran 91% before the bell. During a news halt, it priced 1.5M new shares at $3.82. Here’s what the SEC filings showed beforehand.
1 upvotes · 1 comments
All social signals and their track records

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
KERSTEN GEERT R was granted 2,621 shares
Chief Executive Officer @ $2.06 ($5.4K)
Sep 30, 2026 Insider
PRICHEP PATRICIA B was granted 2,082 shares
Chief Financial Officer @ $2.06 ($4.3K)
Sep 30, 2026 Insider
TALOR EYAL was granted 1,165 shares
Chief Scientific Officer @ $2.06 ($2.4K)
Aug 12, 2026 Earnings calendar
CVM Q3 2026 Earnings Scheduled — 2026-08-12
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
572,460 shares ($595.4K)
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — DOUBLED
543,079 shares ($564.8K)
Jun 16, 2026 SEC
CEL-SCI Corporation completed a best-efforts offering of 2,500,000 shares at $1.00 per share for gross proceeds of…
8-K — Impact 6/10
Jun 15, 2026 SEC
CEL-SCI is offering 2,500,000 shares at $1.00 per share in a best-efforts offering with no minimum, targeting $2.5M…
424B5 — Impact 6/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 12, 2026
Earnings date
CVM Q3 2026 Earnings Scheduled — 2026-08-12
Jul 31, 2026
Short interest
Short Interest: CVM up 67% to 1.2M shares
Settlement 2026-07-31 | Days to cover: 3.79 | ≈6.87% of shares outstanding (est.)
May 12, 2026
Earnings date
CVM Q2 2026 Earnings Scheduled — 2026-05-12

SecBot reports

6 filings · 1 bullish · 3 bearish · 2 mixed
All CVM filing & press-release reports (6)